The genetic basis for ovarian cancer predisposition was originally established with the identification of BRCA1 (OMIM# 113705) and BRCA2 (OMIM# 600185), which are both tumor suppressor genes implicated in the mechanism of Homologous Recombination (HR) repair of DNA double-strand breaks [10]. This evidence concerns the gene BRCA2 and ovarian cancer.